3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

54,093

44,713

 

 

受取手形、売掛金及び契約資産

21,178

19,378

 

 

有価証券

15,992

5,992

 

 

商品及び製品

8,805

7,567

 

 

仕掛品

2,311

2,578

 

 

原材料及び貯蔵品

7,904

8,970

 

 

未収還付法人税等

120

2,068

 

 

未収消費税等

70

1,302

 

 

その他

915

1,478

 

 

貸倒引当金

△0

-

 

 

流動資産合計

111,393

94,051

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

44,001

44,695

 

 

 

 

減価償却累計額

△28,470

△28,914

 

 

 

 

建物及び構築物(純額)

15,530

15,780

 

 

 

機械装置及び運搬具

17,181

19,325

 

 

 

 

減価償却累計額

△14,689

△14,549

 

 

 

 

機械装置及び運搬具(純額)

2,491

4,775

 

 

 

工具、器具及び備品

8,760

9,069

 

 

 

 

減価償却累計額

△7,049

△7,084

 

 

 

 

工具、器具及び備品(純額)

1,711

1,984

 

 

 

土地

3,867

2,676

 

 

 

建設仮勘定

4,027

1,916

 

 

 

有形固定資産合計

27,629

27,134

 

 

無形固定資産

 

 

 

 

 

のれん

5,459

5,399

 

 

 

販売権

10,467

12,201

 

 

 

仕掛研究開発

5,446

5,495

 

 

 

その他

854

1,195

 

 

 

無形固定資産合計

22,228

24,291

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

18,875

18,730

 

 

 

長期前払費用

4,352

3,091

 

 

 

退職給付に係る資産

4,159

4,846

 

 

 

繰延税金資産

4,065

5,367

 

 

 

その他

674

704

 

 

 

投資その他の資産合計

32,126

32,740

 

 

固定資産合計

81,984

84,166

 

資産合計

193,377

178,217

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

8,186

7,428

 

 

電子記録債務

136

138

 

 

短期借入金

3,850

3,850

 

 

未払金

6,311

4,310

 

 

未払費用

1,145

1,516

 

 

未払法人税等

7,285

248

 

 

賞与引当金

1,154

1,019

 

 

役員賞与引当金

86

55

 

 

その他

2,198

2,236

 

 

流動負債合計

30,354

20,803

 

固定負債

 

 

 

 

従業員株式給付引当金

-

61

 

 

株式給付引当金

163

196

 

 

退職給付に係る負債

4,954

4,716

 

 

繰延税金負債

4,469

4,405

 

 

その他

800

414

 

 

固定負債合計

10,388

9,794

 

負債合計

40,742

30,597

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

23,853

23,853

 

 

資本剰余金

12,932

11,406

 

 

利益剰余金

135,242

125,625

 

 

自己株式

△28,233

△23,776

 

 

株主資本合計

143,794

137,109

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

6,257

6,806

 

 

為替換算調整勘定

△57

754

 

 

退職給付に係る調整累計額

2,640

2,949

 

 

その他の包括利益累計額合計

8,840

10,509

 

純資産合計

152,635

147,619

負債純資産合計

193,377

178,217

 

E00935 45210 科研製薬株式会社 KAKEN PHARMACEUTICAL CO., LTD. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 45210 2026-05-13 45210 2025-04-01 2026-03-31 45210 2025-04-01 2026-03-31 jppfs_cor:CapitalStockMember 45210 2025-04-01 2026-03-31 jppfs_cor:CapitalSurplusMember 45210 2025-04-01 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 45210 2025-04-01 2026-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 45210 2025-04-01 2026-03-31 jpcrp_cor:ReconcilingItemsMember 45210 2025-04-01 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45210 2025-04-01 2026-03-31 jpcrp_cor:ReportableSegmentsMember 45210 2025-04-01 2026-03-31 jppfs_cor:RetainedEarningsMember 45210 2025-04-01 2026-03-31 jppfs_cor:ShareholdersEquityMember 45210 2025-04-01 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45210 2025-04-01 2026-03-31 jppfs_cor:TreasuryStockMember 45210 2025-04-01 2026-03-31 tse-acedjpfr-45210:MedicineReportableSegmentsMember 45210 2025-04-01 2026-03-31 tse-acedjpfr-45210:RealEstateReportableSegmentsMember 45210 2025-04-01 2026-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 45210 2025-04-01 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45210 2025-04-01 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45210 2026-03-31 45210 2026-03-31 jppfs_cor:CapitalStockMember 45210 2026-03-31 jppfs_cor:CapitalSurplusMember 45210 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 45210 2026-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 45210 2026-03-31 jpcrp_cor:ReconcilingItemsMember 45210 2026-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45210 2026-03-31 jpcrp_cor:ReportableSegmentsMember 45210 2026-03-31 jppfs_cor:RetainedEarningsMember 45210 2026-03-31 jppfs_cor:ShareholdersEquityMember 45210 2026-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45210 2026-03-31 jppfs_cor:TreasuryStockMember 45210 2026-03-31 tse-acedjpfr-45210:MedicineReportableSegmentsMember 45210 2026-03-31 tse-acedjpfr-45210:RealEstateReportableSegmentsMember 45210 2026-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 45210 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45210 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45210 2024-04-01 2025-03-31 45210 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 45210 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 45210 2024-04-01 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 45210 2024-04-01 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 45210 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 45210 2024-04-01 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45210 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 45210 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 45210 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 45210 2024-04-01 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45210 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 45210 2024-04-01 2025-03-31 tse-acedjpfr-45210:MedicineReportableSegmentsMember 45210 2024-04-01 2025-03-31 tse-acedjpfr-45210:RealEstateReportableSegmentsMember 45210 2024-04-01 2025-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 45210 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45210 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45210 2025-03-31 45210 2025-03-31 jppfs_cor:CapitalStockMember 45210 2025-03-31 jppfs_cor:CapitalSurplusMember 45210 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 45210 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 45210 2025-03-31 jpcrp_cor:ReconcilingItemsMember 45210 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45210 2025-03-31 jpcrp_cor:ReportableSegmentsMember 45210 2025-03-31 jppfs_cor:RetainedEarningsMember 45210 2025-03-31 jppfs_cor:ShareholdersEquityMember 45210 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 45210 2025-03-31 jppfs_cor:TreasuryStockMember 45210 2025-03-31 tse-acedjpfr-45210:MedicineReportableSegmentsMember 45210 2025-03-31 tse-acedjpfr-45210:RealEstateReportableSegmentsMember 45210 2025-03-31 jpcrp_cor:UnallocatedAmountsAndEliminationMember 45210 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45210 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 45210 2024-03-31 45210 2024-03-31 jppfs_cor:CapitalStockMember 45210 2024-03-31 jppfs_cor:CapitalSurplusMember 45210 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 45210 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 45210 2024-03-31 jppfs_cor:RetainedEarningsMember 45210 2024-03-31 jppfs_cor:ShareholdersEquityMember 45210 2024-03-31 jppfs_cor:TreasuryStockMember 45210 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 45210 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure